Eli Lilly (LLY) Stock Edges Lower as $2.88B Merida Biosciences Acquisition Announced
Eli Lilly (LLY) stock falls slightly after unveiling a $2.88B cash deal to acquire Merida Biosciences, gaining access to promising autoimmune therapies.
The post Eli Lilly (LLY) Stock Edges Lower as $2.88B Merida Biosciences Acquisition Announced appeared first on Blockonomi.
Source: Source: Blockonomi